Preneoplastic mammary tumor markers: Cripto and amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice

International Journal of Cancer

Volumn 81, Issue 4, 1999, Pages 588-591

  Niemeyer, Christina C ^a,b   Spencer Dene, Bradley ^b   Wu, Jie Xin ^b   Adamson, Eileen D ^b  

^a Structural Bioinformatics Inc   (United States)

^b BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST HYPERPLASIA; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; ONCOGENE NEU; POLYOMA VIRUS; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; ANTIGENS, VIRAL, TUMOR; ANTINEOPLASTIC AGENTS; CELL DIVISION; EPIDERMAL GROWTH FACTOR; FEMALE; GENES, ERBB-2; GLYCOPROTEINS; GROWTH SUBSTANCES; HUMANS; HYPERPLASIA; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; MICE, TRANSGENIC; NEOPLASM PROTEINS; ONCOGENES; POLYOMAVIRUS; PRECANCEROUS CONDITIONS; PREGNANCY; RECEPTOR, ERBB-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0032908277     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990517)81:4<588::AID-IJC14>3.0.CO;2-I     Document Type: Article

References (20)

1. BARNARD, J. A., GRAVES-DEAL, R., PITTELKOW M. R., DUBOIS, R., COOK, P., RAMSEY, G. W., BISHOP, P. R., DAMSTRUP, L. and COFFEY, R. J., Auto-and cross-induction within the mammalian epidermal growth factor-related peptide family. J. biol Chem., 269, 22817-22822 (1994).
2. BRANDT, R., NORMANNO, N., GULLICK, W. J., LIN, J.-H., HARKINS, R., SCHEIDER, D., JONES, B.-W., CIARDIELLO, F., PERSICO, M. G., ARMENANTE, F., KIM, N. and SALOMON, D. S., Identification and biological characterization of an Epidermal Growth Factor-related protein: Cripto-1. J. biol. Chem., 269, 17320-17328 (1994).
3. COHEN, S., FAVA, R. A. and SAWYER, S. T., Purification and characterization of epidermal growth factor receptor/protein kinase from normal mouse liver. Proc. nat. Acad. Sci. (Wash.), 79, 6237-6241 (1982).
4. GUY, C. T., CARDIFF, R. D. and MULLER, W. J., Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. cell. Biol., 12, 954-961 (1992a).
5. GUY, C. T., WEBSTER, M. A., SCHALLER, M., PARSONS, T. J., CARDIFF, R. D. and MULLER, W. J., Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. nat. Acad. Sci.(Wash.)., 89, 10578-10582 (1992b).
6. HYNES, N. E. and STERN, D. F. The biology of erbb-2/neu/her-2 and its role in cancer. biochim biophys acta., 1198, 165-184 (1994).
7. JHAPPAN, C., STAHLE, C., HARKINS, R. N., FAUSTO, N., SMITH, G. H. and MERLINO, G. T., TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell, 61, 1137-1146 (1990).
8. JOHNSON, G.R., KANNAN, B., SHOYAB, M. and STROMBERG, EK., AmphireguHn induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2: evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J. biol. Chem., 268, 2924-2931 (1993)
9. JOHNSON, G.R., SAEKI, T., GORDON, A.W. SHOYAB, M., SALOMON, D.S. and STROMBERG, K., Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J. Cell Biol., 118, 741-751 (1992).
10. KENNEY, N. J., HUANG. R. P., JOHNSON, G. R., Wu, J. X., OKAMURA, D., MATHENY, W., KORDON, E., GULLICK, W. J., PLOWMAN, G., SMITH, G. H., SALOMON, D.S. and ADAMSON, E.D., Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland. Mol. Reprod. Develop. 41, 277-286 (1995).
11. KENNEY, N.J., SMITH, G.H., MAROULAKOU, I.G., GREEN, J.H., MULLER, W.J., CALLAHAN, R., SALOMON, D.S. and DICKSON, R.B., Detection of Amphiregulin and Cripto-1 in mammary tumors from transgenic mice. Mol. Carcinogenesis, 15, 44-56 (1996a).
12. KENNEY, N. J., SMITH, G. H., ROSENBERG, K., CUTLER, M. L. and DICKSON, R. B., Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differentiation, 7, 1769-1781 (1996b).
13. KING, C. R., KRAUS, M. H. AND AARONSON, S. A., Amplification of novel v-erb-related gene in a human mammary carcinoma. Science, 229, 974-976 (1985).
14. KLIJN, J. G., BERNS, P. M., SCHMITZ, P. I., and FOEKENS, J. A., The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients. Endocrine Rev., 13(1), 3-17 (1992).
15. NIEMEYER, C.C., PERSICO, M.G. and ADAMSON, E. D., Cripto: roles in mammary cell growth, survival, differentiation and transformation., Cell Death Differentiation, 5, 440-449 (1998).
16. NORMANNO, N., SELVAN, M. P., SAEKI, T., JOHNSON, G., BRANDT, R., KIM, N., CIARDIELLO, F., SHOYAB, M., PLOWMAN, G., TODARO, G., and SALOMON, D. S., Amphiregulin as an autocrine growth factor for c-Ha-ras and c-erbB-2 transformed human mammary epithelial cells. Proc. nat. Acad. Sci. (Wash.), 91, 2790-2794 (1994).
17. QI, C. F., LISCIA, D. S., NORMANNO, N., MERLO, G., JOHNSON, G. R., GULLICK, W. J., CIARDIELLO, F., SAEKI, T., BRANDT, R., KIM, N., KENNEY, N., and SALOMON, D.S., Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Brit. J. Cancer, 69, 903-910 (1994).
18. SALOMON, D.S., NORMANNO, N., CIARDIELLO, F., BRANDT, R., SHOYAB, M., and TODARO, G. J., The role of amphiregulin in breast cancer. Breast Cancer Res. Treat., 33, 103-114 (1995).
19. SCHECHTER, A. L., STERN, D. F., VAIDYANATHAN, L., DECKER, S. J., DREBIN, J. A., GREENE, M. I., and WEINBERG, R. A., The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen. Nature (Lond.), 312, 513-516 (1984).
20. SMITH, G. H., SHARP, R., KORDON, E. C., JHAPPAN, C., and MERLINO, G., Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Amer. J. Pathot., 147, 1081-1096 (1995).